176 Results for "

VON

" in MedChemExpress (MCE) Product Catalog:
Products (176)

176 Results for "VON" in MCE Product Catalog:

30
30 Publications Verification
Cat. No.: HY-100972
CAS No.: 1949837-12-0
Purity:  98.87%
Research Areas:  

Cancer

ARV-771 is a potent BET PROTAC based on E3 ligase von Hippel-Lindau with Kds of 34 nM, 4.7 nM, 8.3 nM, 7.6 nM, 9.6 nM, and 7.6 nM for BRD2(1), BRD2(2), BRD3(1), BRD3(2), BRD4(1), and BRD4(2), respectively .
loading...
    loading...
25
25 Cited Publications
Cat. No.: HY-107425
CAS No.: 1797406-69-9
Purity:  99.86%
Research Areas:  

Cancer

MZ 1 is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. MZ 1 potently and rapidly induces reversible, long-lasting, and selective removal of BRD4 over BRD2 and BRD3. Kds of 382/120, 119/115, and 307/228 nM for BRD4 BD1/2, BRD3 BD1/2, and BRD2 BD1/2, respectively .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-120217
CAS No.: 1448188-62-2
Purity:  99.64%
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

VH032 is a VHL ligand used in the recruitment of the von Hippel-Lindau (VHL) protein. VH032 is a VHL/HIF-1α interaction inhibitor with a Kd
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-111519
CAS No.: 2170695-14-2
Purity:  99.89%
Research Areas:  

Cancer

dTRIM24 is a selective bifunctional degrader of TRIM24 based on PROTAC, consists of ligands for von Hippel-Lindau and TRIM24.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-145514D
CAS No.: 2451573-86-5
Target:  

PROTACs FKBP

Research Areas:  

Cancer

dTAGV-1 is a selective FKBP12 F36V PORTAC degrader. dTAGV-1 induces rapid degradation of FKBP12 F36V-tagged oncogenic fusion proteins, triggering collapse of downstream cellular signaling pathways, reduced proliferative capacity of cancer cells, and decreased levels of target proteins. dTAGV-1 is applicable to functional validation studies of cancer and undegradable oncoproteins .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-145514
CAS No.: 2624313-15-9
Purity:  99.97%
Target:  

PROTACs FKBP

Research Areas:  

Cancer

dTAGV-1 TFA is a selective FKBP12 F36V PORTAC degrader. dTAGV-1 TFA induces rapid degradation of FKBP12 F36V-tagged oncogenic fusion proteins, triggering collapse of downstream cellular signaling pathways, reduced proliferative capacity of cancer cells, and decreased levels of target proteins. dTAGV-1 TFA is applicable to functional validation studies of cancer and undegradable oncoproteins .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-145514C
CAS No.: 2624313-16-0
Purity:  98.83%
Target:  

PROTACs FKBP

Research Areas:  

Cancer

dTAGV-1 hydrochloride is a selective FKBP12 F36V PORTAC degrader. dTAGV-1 hydrochloride induces rapid degradation of FKBP12 F36V-tagged oncogenic fusion proteins, triggering collapse of downstream cellular signaling pathways, reduced proliferative capacity of cancer cells, and decreased levels of target proteins. dTAGV-1 hydrochloride is applicable to functional validation studies of cancer and undegradable oncoproteins .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-125878
CAS No.: 2381320-35-8
Purity:  99.89%
Synonyms: SGK3-PROTAC1
Target:  

PROTACs SGK

Research Areas:  

Cancer

PROTAC SGK3 degrader-1 (SGK3-PROTAC1), a chemical probe, is a von Hippel-Lindau ligand-based SKG3 PROTAC composed of a PEG3-C4-OBn (HY-130620) alkyl linker, an SGK3 degrader (red structure), and a VHL ligand (HY-150803, blue structure). PROTAC SGK3 degrader-1 (0.3 μM) induced 50% endogenous SGK3 degradation within 2 hours, and 80% SGK3 degradation was observed at 8 hours, accompanied by loss of phosphorylation of NDRG1 (SGK3 substrate) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-123921
CAS No.: 2230821-27-7
Purity:  99.98%
Target:  

PROTACs EGFR

Research Areas:  

Cancer

Gefitinib-based PROTAC 3, conjugating an EGFR binding element to a von Hippel-Lindau ligand via a linker, induces EGFR degradation with DC50s of 11.7 nM and 22.3 nM in HCC827(exon 19 del) and H3255 (L858R mutantion) cells, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-130492
CAS No.: 1973403-00-7
Purity:  99.88%
Research Areas:  

Cancer

ARCC-4 is a low-nanomolar Androgen Receptor (AR) degrader based on PROTAC, with a DC50 of 5?nM. ARCC-4 is an enzalutamide-based von Hippel-Lindau (VHL)-recruiting AR PROTAC and outperforms enzalutamide. ARCC-4 effectively degrades clinically relevant AR mutants associated with antiandrogen therapy .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-101763A
CAS No.: 1448189-80-7
Purity:  99.83%
Synonyms: VH032-NH2 monohydrochloride; VHL ligand 1 monohydrochloride
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

(S,R,S)-AHPC (VH032-NH2; VHL ligand 1) hydrochloride is the VH032-based VHL ligand used in the recruitment of the von Hippel-Lindau (VHL) protein .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-125845
CAS No.: 1448297-52-6
Purity:  99.09%
Synonyms: VH032-NH2; VHL ligand 1
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

(S,R,S)-AHPC (VH032-NH2) is the VH032-based VHL ligand used in the recruitment of the von Hippel-Lindau (VHL) protein. (S,R,S)-AHPC can be connected to the ligand for protein (e.g., BCR-ABL1) by a linker to form PROTACs (e.g., GMB-475). GMB-475 induces the degradation of BCR-ABL1 with an IC50 of 1.11 μM in Ba/F3 cells .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-130604
CAS No.: 2365172-42-3
Purity:  99.61%
Research Areas:  

Inflammation/Immunology Cancer

DT2216 is a potent and selective BCL-XL (Bcl-2 family member) degrader based on PROTAC technology. DT2216 causes effective degradation of BCL-XL protein by recruiting Von Hippel-Lindau (VHL) E3 ubiquitin ligase. DT2216 inhibits various BCL-XL-dependent leukemia and cancer cells but considerably less toxic to platelets .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-125845A
CAS No.: 2115897-23-7
Purity:  99.42%
Synonyms: (S,S,S)-VH032-NH2 hydrochloride
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

(S,S,S)-AHPC ((S,S,S)-VH032-NH2) hydrochloride is a von Hippel-Lindau (VHL) amino building block. (S,S,S)-AHPC (Compound 27) is a ligand used as a negative control for (S,R,S)-AHPC (HY-125845). (S,R,S)-AHPC is the VH032-based VHL ligand used in the recruitment of the VHL protein .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-112376
CAS No.: 2010159-47-2
Purity:  98.16%
Research Areas:  

Cancer

MZP-54 is a PROTAC connected by ligands for von Hippel-Lindau and BRD3/4, with a Kd of 4 nM for Brd4 BD2.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-137516
CAS No.: 2502156-03-6
Purity:  98.16%
Target:  

PROTACs Ras

Research Areas:  

Cancer

LC-2 is a potent and first-in-class von Hippel-Lindau-based PROTAC capable of degrading endogenous KRAS G12C, with DC50s between 0.25 and 0.76 μM . LC-2 covalently binds KRAS G12C with a MRTX849 warhead and recruits the E3 ligase VHL, inducing rapid and sustained KRAS G12C degradation leading to suppression of MAPK signaling in both homozygous and heterozygous KRAS G12C cell lines .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99227
CAS No.: 915810-67-2
Synonyms: ALX-0681; ALX-0081
Caplacizumab (His Tag) is a humanized anti-von Willebrand factor (vWF) nanobody. Caplacizumab (His Tag) inhibits the binding of vWF with platelet glycoprotein (GP) Ibα. Caplacizumab (His Tag) inhibits the vWF-mediated platelet adhesion and prevents further microthrombi formation. Caplacizumab (His Tag) can be used for the research of thrombotic thrombocytopenic purpura (TTP) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-141438
CAS No.: 2719051-84-8
Purity:  99.57%
Research Areas:  

Cancer

SIM1 is a potent von Hippel-Lindau (VHL)-based trivalent PROTAC capable of degradation for all BET family members, with preference for BRD2 degradation (IC50=1.1 nM; Kd=186 nM). SIM1 shows sustained anti-cancer activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-130714
CAS No.: 2305936-56-3
Purity:  99.41%
Target:  

PROTACs

Research Areas:  

Cancer

TD-165 is a PROTAC-based cereblon (CRBN) degrader. TD-165 comprises a cereblon (CRBN) ligand binding group, a linker and an von Hippel-Landau (VHL) binding group .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-111593
CAS No.: 2244684-49-7
Purity:  99.40%
Target:  

PROTACs

Research Areas:  

Cancer

Homo-PROTAC pVHL30 degrader 1 is a potent pVHL30 degrader based on PROTAC , consists of two ligands of von Hippel-Lindau.
loading...
    loading...